CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

65Citations
Citations of this article
120Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CX3C chemokine ligand 1 (CX3CL1) is an intriguing chemokine belonging to the CX3C family. CX3CL1 is secreted by neurons and plays an important role in modulating glial activation in the central nervous system after binding to its sole receptor CX3CR1 which mainly is expressed on microglia. Emerging data highlights the beneficial potential of CX3CL1-CX3CR1 in the pathogenesis of Alzheimer's disease (AD), a common progressive neurodegenerative disease, and in the progression of which neuroinflammation plays a vital role. Even so, the importance of CX3CL1/CX3CR1 in AD is still controversial and needs further clarification. In this review, we make an attempt to present a concise map of CX3CL1-CX3CR1 associated with AD to find biomarkers for early diagnosis or therapeutic interventions.

Cite

CITATION STYLE

APA

Chen, P., Zhao, W., Guo, Y., Xu, J., & Yin, M. (2016). CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2016/8090918

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free